Summary

This study is designed to evaluate the utility of this biomarker in prostate cancer diagnosis and/or prognosis. We proposed to study 200 cases of PCa specimens and its noram counterpart already banked in our Department[Single Quote]s tissue bank. The outcome can help us not only to understand the natural history of PCa in terms of epigenetic alteration, but also to have better prognostic tools for the management of PCa patients.

Participant Eligibility

Subjects will be the surgical specimens obtained from prostate cancer patients that have been archived in our tissue bank.